Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yves-Marie Lahaie & Hervé Watier. (2017) Contribution of physiologists to the identification of the humoral component of immunity in the 19th century. mAbs 9:5, pages 774-780.
Read now
Read now
André Pèlegrin, Arnaud Daguet & Hervé Watier. (2014) MAbImprove. mAbs 6:4, pages 803-804.
Read now
Read now
Janardan P. Pandey. (2012) Mechanism of resistance to cetuximab therapy in colorectal cancer. mAbs 4:5, pages 553-554.
Read now
Read now
Alain Beck & Janice M. Reichert. (2012) Marketing approval of mogamulizumab. mAbs 4:4, pages 419-425.
Read now
Read now
Janice M. Reichert. (2012) mAbs’s communication networks. mAbs 4:2, pages 133-133.
Read now
Read now
Articles from other publishers (14)
Pierre Bruhns & Sylvie Chollet-Martin. (2021) Mechanisms of human drug-induced anaphylaxis. Journal of Allergy and Clinical Immunology 147:4, pages 1133-1142.
Crossref
Crossref
Theodora Bejan-Angoulvant & Joachim Alexandre. (2020) Mécanismes d’action et toxicités potentielles des anticorps monoclonaux. médecine/sciences 35:12, pages 1114-1120.
Crossref
Crossref
Andrea GrignolioAndrea Grignolio. 2018. Vaccines: Are they Worth a Shot?. Vaccines: Are they Worth a Shot?
111
135
.
Roy Jefferis. 2017. Biosimilar Drug Product Development. Biosimilar Drug Product Development
109
150
.
Roy Jefferis. 2021. Advances in Glycobiotechnology. Advances in Glycobiotechnology
281
318
.
Roy Jefferis. 2016. Biosimilars of Monoclonal Antibodies. Biosimilars of Monoclonal Antibodies
155
199
.
Roy Jefferis. (2016) Posttranslational Modifications and the Immunogenicity of Biotherapeutics. Journal of Immunology Research 2016, pages 1-15.
Crossref
Crossref
Roy Jefferis. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
171
200
.
Roy Jefferis. 2014. State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 1. Monoclonal Antibody Therapeutics: Structure, Function, and Regulatory Space. State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 1. Monoclonal Antibody Therapeutics: Structure, Function, and Regulatory Space
35
68
.
Aurélie Grandvuillemin, Anne Disson-Dautriche, Ghada Miremont-Salamé, Annie Fourrier-Reglat & Catherine Sgro. (2012) Cetuximab infusion reactions: French pharmacovigilance database analysis. Journal of Oncology Pharmacy Practice 19:2, pages 130-137.
Crossref
Crossref
Nancy E. Everds & Jacqueline M. Tarrant. (2013) Unexpected Hematologic Effects of Biotherapeutics in Nonclinical Species and in Humans. Toxicologic Pathology 41:2, pages 280-302.
Crossref
Crossref
D. Jiao, Y. Liu, X. Lu, Q. Pan, J. Zheng, B. Liu, Y. Liu, Y. Wang & N. Fu. (2012)
Characteristics of anaphylaxis‐inducing
I
g
G
immune complexes triggering murine passive systemic anaphylaxis
. Allergy 68:2, pages 236-245.
Crossref
Crossref
Olivier Bouché & Pierre Laurent-PuigY. Pointreau, C. Fréneaux, T. Bejan-Angoulvant & H. Watier. 2013. Médecine personnalisée en cancérologie digestive. Médecine personnalisée en cancérologie digestive
193
206
.
Yoann Pointreau, Scott P. Commins, Gilles Calais, Hervé Watier & Thomas A.E. Platts-Mills. (2012) Fatal Infusion Reactions to Cetuximab: Role of Immunoglobulin E–Mediated Anaphylaxis. Journal of Clinical Oncology 30:3, pages 334-334.
Crossref
Crossref